Safety of a fifth dose of the Lyme disease vaccine
Part of Infections clinical trials.
This study is for people who have already received four doses of the Lyme vaccine (VLA15) in a previous study. It tests whether a fifth dose is safe and helps the body build more protection against Lyme disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have received all four doses of the Lyme vaccine in the earlier study (C4601003).
- You must have a blood sample taken at the last visit of that study (called V7).
- You need to be in good general health, as judged by a doctor.
- You must be willing to follow the study schedule and procedures.
- You cannot be pregnant or breastfeeding.
- You cannot have serious health issues like bleeding disorders, weak immune system, or cancer, and you must not be on certain medications (e.g., steroids, blood thinners).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system reacts to the bacteria that cause Lyme disease in people with a skin condition called ACA. It may help doctors understand the disease better and guide future treatments.
This study evaluates and treats people who currently have active Lyme disease, as defined by CDC criteria. It aims to provide expert care and follow-up while studying the disease.
This study looks at the health of people who have had Lyme disease, including those with ongoing symptoms after treatment, and those who have recovered or never had it. It aims to understand the disease and find better ways to manage it.
This study looks at how your body's immune system reacts to a tick bite. It may help doctors understand and prevent tick-borne diseases, which are illnesses spread by ticks, like Lyme disease.
This trial is testing a new blood test to help diagnose Lyme disease (borrelia infection) in children. If you are at the emergency room with symptoms that might be Lyme disease and you have a healthy immune system, you might be able to join.
This trial tests whether taVNS (a noninvasive nerve stimulation done through the skin near the ear) can reduce long-lasting symptoms after Lyme disease. It targets people whose symptoms have stayed for months after standard antibiotic treatment.
Hear when a new Lyme Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.